Incannex Healthcare

IXHLNasdaq Australia Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$37.748 M

$3.16 +1.45%

Close of 7 Aug 2026

Revenue

$12.0K

#3645 by revenue

Earnings

-$46.9M

Loss-making

Shares outstanding

11,964,554

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#362Radiopharm TheranosticsRADX$40.3M
#363CervoMedCRVO$38.8M
#364Incannex HealthcareIXHL$37.7M
#365VeruVERU$37.4M
#366ApollomicsAPLM$37.1M

Where these numbers come from

Share counts and financials for Incannex Healthcare are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.